HUP0100668A2 - Virulenciával kapcsolatos nukleinsavszekvenciák és alkalmazásuk - Google Patents

Virulenciával kapcsolatos nukleinsavszekvenciák és alkalmazásuk

Info

Publication number
HUP0100668A2
HUP0100668A2 HU0100668A HUP0100668A HUP0100668A2 HU P0100668 A2 HUP0100668 A2 HU P0100668A2 HU 0100668 A HU0100668 A HU 0100668A HU P0100668 A HUP0100668 A HU P0100668A HU P0100668 A2 HUP0100668 A2 HU P0100668A2
Authority
HU
Hungary
Prior art keywords
virulence
identify
subject
nucleic acid
acid molecules
Prior art date
Application number
HU0100668A
Other languages
English (en)
Inventor
Frederick M. Ausubel
Hui Cao
Eliana Drenkard
Howard M. Goodman
Shalina Mahajan-Miklos
Laurence G. Rahme
Man-Wah Tan
John Tsongalis
Original Assignee
The General Hospital Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The General Hospital Corp. filed Critical The General Hospital Corp.
Publication of HUP0100668A2 publication Critical patent/HUP0100668A2/hu
Publication of HUP0100668A3 publication Critical patent/HUP0100668A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/21—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pseudomonadaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Abstract

A találmány tárgyát képezik virulenciával kapcsolatosnukleinsavmolekulák, a nukleinsavmolekulákat expresszáló gazdasejtekés alkalmazásuk egy patogén virulenciafaktor expressziójánakcsökkentésére képes vegyület azonosítására. A találmány tárgyátképezik továbbá patogenitással kapcsolatos polipeptidek ésalkalmazásuk a polipeptidet kötő vegyület azonosítására. A találmánytárgyát képezi továbbá Pseudomonas sejt virulenciáját gátló vegyületazonosítására szolgáló eljárás. A találmány szerinti megoldás emlősbenegy patogén által okozott fertőzés kezelésére alkalmazható. Ó
HU0100668A 1997-11-25 1998-11-25 Virulence-associated nucleic sequences and uses thereof HUP0100668A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6651797P 1997-11-25 1997-11-25
PCT/US1998/025247 WO1999027129A1 (en) 1997-11-25 1998-11-25 Virulence-associated nucleic acid sequences and uses thereof

Publications (2)

Publication Number Publication Date
HUP0100668A2 true HUP0100668A2 (hu) 2001-06-28
HUP0100668A3 HUP0100668A3 (en) 2005-01-28

Family

ID=22070007

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100668A HUP0100668A3 (en) 1997-11-25 1998-11-25 Virulence-associated nucleic sequences and uses thereof

Country Status (12)

Country Link
US (3) US6355411B1 (hu)
EP (1) EP1040200A4 (hu)
JP (1) JP2002505849A (hu)
KR (1) KR20010032432A (hu)
CN (1) CN1309720A (hu)
AU (1) AU763126B2 (hu)
BR (1) BR9812791A (hu)
CA (1) CA2310561A1 (hu)
HU (1) HUP0100668A3 (hu)
IL (1) IL136349A0 (hu)
NZ (1) NZ504669A (hu)
WO (1) WO1999027129A1 (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756493B1 (en) * 1998-09-01 2004-06-29 Antex Biologics, Inc. Nucleic acid sequence and uses thereof
US6693186B2 (en) * 1998-09-01 2004-02-17 Antex Biologics Inc Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
EP2382982A3 (en) * 2001-08-24 2012-02-22 Neuren Pharmaceuticals Limited Neural regeneration peptide and methods for their use in treatment of brain damage
US20050119302A1 (en) * 2001-10-30 2005-06-02 Rahme Laurence G. Methods for the prevention or treament of bacterial and fungal infections
AU2003272339A1 (en) * 2002-09-12 2004-04-30 The General Hospital Corporation Virulence-associated nucleic acids and proteins and uses thereof
US8445639B2 (en) * 2006-05-15 2013-05-21 Avidbiotics Corporation Recombinant bacteriophage and methods for their use
DK2021358T3 (da) * 2006-05-15 2012-07-16 Avidbiotics Corp Modificerede bakteriociner og fremgangsmåder til anvendelse af disse
US7700729B2 (en) * 2006-05-15 2010-04-20 Avidbiotics Corporation Modified bacteriocins and methods for their use
EP2166769B1 (en) 2007-06-29 2017-04-05 Sharp Kabushiki Kaisha Image encoding device, image encoding method, image decoding device, image decoding method, program, and recording medium
CA2732305A1 (en) * 2008-07-30 2010-02-04 General Electric Company Method for evaluating the virulence of pathogenic biphasic bacteria
US9237327B2 (en) * 2008-09-23 2016-01-12 Dolby Laboratories Licensing Corporation Encoding and decoding architecture of checkerboard multiplexed image data
US10406211B2 (en) 2011-04-25 2019-09-10 California Institute Of Technology Methods and system for interfering with viability of bacteria and related compounds and compositions
US9926526B2 (en) * 2011-04-25 2018-03-27 California Institute Of Technology Methods and system for interfering with viability of bacteria and related compounds and compositions
CN117462693A (zh) 2012-02-27 2024-01-30 阿穆尼克斯运营公司 Xten缀合组合物和制造其的方法
US9334542B2 (en) * 2012-04-02 2016-05-10 Life Technologies Corporation Compositions and methods for detection of microorganisms of the Mycobacterium avium complex excluding Mycobacterium avium paratuberculosis
WO2013151647A1 (en) 2012-04-02 2013-10-10 Life Technologies Corporation Compositions and methods for detection of mycobacterium avium paratuberculosis
US10913936B2 (en) 2016-03-22 2021-02-09 California Institute Of Technology Phenazine degrading agents and related compositions, methods and systems for interfering with viability of bacteria

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0411897A (ja) * 1989-10-04 1992-01-16 Sumitomo Chem Co Ltd 抗緑膿菌外毒素ａヒトモノクローナル抗体
US6461854B1 (en) * 1995-03-28 2002-10-08 The General Hospital Corporation Methods of screening compounds useful for prevention of infection or pathogenicity
US7166270B1 (en) 1995-03-28 2007-01-23 The Netherlands Cancer Institute Methods of screening compounds useful for prevention of infection or pathogenicity
US5994066A (en) 1995-09-11 1999-11-30 Infectio Diagnostic, Inc. Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
GB9608000D0 (en) 1996-04-18 1996-06-19 Smithkline Beecham Plc Novel compounds
GB9607993D0 (en) 1996-04-18 1996-06-19 Smithkline Beecham Plc Novel compounds
GB9607991D0 (en) 1996-04-18 1996-06-19 Smithkline Beecham Plc Novel compounds
GB9619072D0 (en) 1996-09-12 1996-10-23 Smithkline Beecham Plc Novel compounds
US6004556A (en) 1996-10-24 1999-12-21 Smithkline Beecham Corporation Staphylococcus aureus RSBU-1
US5827689A (en) 1996-11-13 1998-10-27 Smithkline Beecham Corporation FabD polynucleotides

Also Published As

Publication number Publication date
HUP0100668A3 (en) 2005-01-28
CN1309720A (zh) 2001-08-22
KR20010032432A (ko) 2001-04-25
JP2002505849A (ja) 2002-02-26
US20070105167A1 (en) 2007-05-10
AU763126B2 (en) 2003-07-10
US20030022349A1 (en) 2003-01-30
IL136349A0 (en) 2001-05-20
EP1040200A1 (en) 2000-10-04
US6355411B1 (en) 2002-03-12
AU1799699A (en) 1999-06-15
NZ504669A (en) 2002-11-26
CA2310561A1 (en) 1999-06-03
BR9812791A (pt) 2000-10-17
WO1999027129A1 (en) 1999-06-03
EP1040200A4 (en) 2005-04-20

Similar Documents

Publication Publication Date Title
HUP0100668A2 (hu) Virulenciával kapcsolatos nukleinsavszekvenciák és alkalmazásuk
EA199700087A1 (ru) Способ ингибирования катепсина к
BR0109062A (pt) Inibidores de frutose-1,6-bisfosfatase de arila
ATE421584T1 (de) Cpg rezeptor (cpg-r) und darauf bezogene methoden
ATE292801T1 (de) Verfahren zum screening von inhibitoren von asp2
EA200401453A1 (ru) Молекулы распознавания на клеточной поверхности, содержащие иммуноглобулиновый домен
ATE230034T1 (de) Verfahren zur aufreinigung von dns
DE69629674D1 (de) Dns-sequenzen des humanen cytomegaloviruses
DE69833660D1 (de) Nukleinsäuresonden zur detektion von candida-spezies
DE59805339D1 (de) Verfahren zum vergleich der kopienzahl von nukleinsäuresequenzen
DE69739346D1 (de) Gereinigtes sr-p70 protein
TR200003624T2 (tr) Yeni poli(ADP-RİBOZ) polimeraz-genleri
DE59508137D1 (de) Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine
BR0014626A (pt) Análise de leptina
DK1051491T3 (da) Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf
DE69732857D1 (de) Nukleinsaeuren und proteine der katze fc-epsilon rezeptor alpha-kette und deren verwendungen
ATE309370T1 (de) Retinoid-metabolisierendes protein
NO20024755D0 (no) Metode
BR0114884A (pt) Compostos calcilìticos
DE60012723D1 (de) Verfahren zur bestimmung von disaccharidasen
ATE397011T1 (de) Verwendung von inhibitoren von asparaginyl- endopeptidase aus säugetieren zur modulierung des immunsystemen
TR199902757T2 (xx) Grup O HIV-1 vir�slerine ba�l� enfeksiyonlar�n tespiti i�in biyolojik testlerde kullan�labilen sentetik peptitler.
CA2177600A1 (fr) Sequences d'acides nucleiques regulatrices et utilisations
ATE329600T1 (de) Verwendung von tagatose zur verbesserung wichtiger blutfaktoren
HUP0104194A2 (hu) Módszer és készlet foszfatázcélzó toxinok kimutatására